21-45134743-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_001112.4(ADARB1):c.-48+6170C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00305 in 530,664 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0032 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0030 ( 3 hom. )
Consequence
ADARB1
NM_001112.4 intron
NM_001112.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0370
Genes affected
ADARB1 (HGNC:226): (adenosine deaminase RNA specific B1) This gene encodes the enzyme responsible for pre-mRNA editing of the glutamate receptor subunit B by site-specific deamination of adenosines. Studies in rat found that this enzyme acted on its own pre-mRNA molecules to convert an AA dinucleotide to an AI dinucleotide which resulted in a new splice site. Alternative splicing of this gene results in several transcript variants, some of which have been characterized by the presence or absence of an ALU cassette insert and a short or long C-terminal region. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.02).
BP6
Variant 21-45134743-C-G is Benign according to our data. Variant chr21-45134743-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 2652783.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.00324 (491/151718) while in subpopulation AMR AF= 0.0113 (173/15282). AF 95% confidence interval is 0.00994. There are 4 homozygotes in gnomad4. There are 252 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ADARB1 | NM_001112.4 | c.-48+6170C>G | intron_variant | ENST00000348831.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ADARB1 | ENST00000348831.9 | c.-48+6170C>G | intron_variant | 1 | NM_001112.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00325 AC: 492AN: 151600Hom.: 4 Cov.: 32
GnomAD3 genomes
AF:
AC:
492
AN:
151600
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00310 AC: 753AN: 242988Hom.: 1 AF XY: 0.00315 AC XY: 416AN XY: 131968
GnomAD3 exomes
AF:
AC:
753
AN:
242988
Hom.:
AF XY:
AC XY:
416
AN XY:
131968
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00298 AC: 1129AN: 378946Hom.: 3 Cov.: 0 AF XY: 0.00289 AC XY: 624AN XY: 215730
GnomAD4 exome
AF:
AC:
1129
AN:
378946
Hom.:
Cov.:
0
AF XY:
AC XY:
624
AN XY:
215730
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00324 AC: 491AN: 151718Hom.: 4 Cov.: 32 AF XY: 0.00340 AC XY: 252AN XY: 74102
GnomAD4 genome
AF:
AC:
491
AN:
151718
Hom.:
Cov.:
32
AF XY:
AC XY:
252
AN XY:
74102
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
15
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2022 | ADARB1: BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at